Pomerantz LLP is investigating claims on behalf of investors of Stitch Fix, Inc. (“Stitch Fix” or the “Company”) (NASDAQ: SFIX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Stitch Fix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. […]

Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc (“Marex” or the “Company”)(NASDAQ: MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”)(NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. (“RCI” or the “Company”)(NASDAQ: RICK). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

PomerantzLLP announces that a securities fraud class action lawsuit has been filed against Sina Corporation (“Sina” or the “Company”)(formerly NASDAQ: SINA) and certain of its executive officers (collectively, “Defendants”)on behalf of investors who sold Sina ordinary shares, including those that sold into the Merger (defined below), between October 13, 2020 and March 22, 2021, inclusive

Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against Fly-E Group, Inc. (“Fly-E” or the “Company”)(NASDAQ: FLYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Corporation (“Quantum” or the “Company”)(NASDAQ: QMCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filedon behalf of investors in the securities ofSpirit Aviation Holdings, Inc. (“Spirit” or the “Company”) (OTCMKTS: FLYYQ).The class action, filed in the United States District Court for the Southern District of Florida, and docketed under 25-cv-61959, is on behalf of a class consisting of all

Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) and certain officers. The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under 25-cv-02496, is on behalf of a class consisting of all persons